HHS Orders Gallo Forum Canceled; Meeting May Be Held After OSI report final – Calabresi
In Brief: NY Judges, Lawyers Form Breast Cancer Alert; Terms of ODAC Chairman, 3 Members Expire
Breast Cancer Vs. Other Cancers In Budget Showdown
ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin
Management Survey Finds Problems At ACS, Advises Change
Coalition On Smoking Or Health to Launch Effort at $5 Tax Increase
DCBDC Advisors Okay New Program In Breast Cancer
Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”









